Celera Corporation

Logo of Celera Corporation

Celera Corporation was a company that played a significant role in the Human Genome Project and the field of genomics. Founded in 1998, Celera was instrumental in sequencing the human genome and advancing the understanding of genetic information.

History

Celera Corporation was established in 1998 by Craig Venter, a prominent scientist in the field of genomics. The company was created with the goal of sequencing the human genome more rapidly and cost-effectively than the publicly funded Human Genome Project. Celera used a technique known as whole genome shotgun sequencing, which allowed for faster sequencing by breaking the genome into smaller fragments and then reassembling them using computational methods.

Human Genome Project

Celera's involvement in the Human Genome Project was both collaborative and competitive. While the publicly funded project aimed to sequence the human genome by 2005, Celera announced its intention to complete the task by 2001. This announcement accelerated the efforts of the public project, leading to a draft sequence being published in 2000.

Technological Innovations

Celera's approach to sequencing involved the use of automated DNA sequencing machines and advanced bioinformatics tools. The company's use of whole genome shotgun sequencing was a significant departure from the hierarchical shotgun sequencing method used by the public project. This innovation allowed Celera to sequence genomes more quickly and efficiently.

Impact on Genomics

The work of Celera Corporation had a profound impact on the field of genomics. By sequencing the human genome, Celera provided valuable data that has been used in numerous biomedical research studies. The company's efforts also highlighted the importance of private sector involvement in scientific research and the potential for public-private partnerships in advancing scientific knowledge.

Acquisition and Legacy

In 2011, Celera Corporation was acquired by Quest Diagnostics, a company specializing in diagnostic information services. Despite the acquisition, Celera's legacy in the field of genomics continues to influence research and development in personalized medicine and genetic testing.

Related pages

• Human Genome Project
• Craig Venter
• Genomics
• Bioinformatics
• Quest Diagnostics